Cite
Aryl hydrocarbon receptor activation ameliorates experimental colitis by modulating the tolerogenic dendritic and regulatory T cell formation.
MLA
Cui, Xiufang, et al. “Aryl Hydrocarbon Receptor Activation Ameliorates Experimental Colitis by Modulating the Tolerogenic Dendritic and Regulatory T Cell Formation.” Cell & Bioscience, vol. 12, no. 1, Apr. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13578-022-00780-z.
APA
Cui, X., Ye, Z., Wang, D., Yang, Y., Jiao, C., Ma, J., Tang, N., & Zhang, H. (2022). Aryl hydrocarbon receptor activation ameliorates experimental colitis by modulating the tolerogenic dendritic and regulatory T cell formation. Cell & Bioscience, 12(1), 1–13. https://doi.org/10.1186/s13578-022-00780-z
Chicago
Cui, Xiufang, Ziping Ye, Di Wang, Yan Yang, ChunHua Jiao, Jingjing Ma, Nana Tang, and Hongjie Zhang. 2022. “Aryl Hydrocarbon Receptor Activation Ameliorates Experimental Colitis by Modulating the Tolerogenic Dendritic and Regulatory T Cell Formation.” Cell & Bioscience 12 (1): 1–13. doi:10.1186/s13578-022-00780-z.